U.S. Water Utilities Stock News

SES AI Corporation announced in January 2026 that it is working with Korea’s Top Material to expand battery cell manufacturing for drones and urban air mobility, while also unveiling its MU-1 Molecular Universe platform, a joint venture with Hisun New Materials, and the completed acquisition of UZ Energy to enter the energy storage systems market. Together, these moves highlight SES AI’s push to build a broader battery technology ecosystem spanning advanced aviation uses, materials...

Key Insights Institutions' substantial holdings in Aura Biosciences implies that they have significant influence over...

Despite an already strong run, MKS Inc. ( NASDAQ:MKSI ) shares have been powering on, with a gain of 37% in the last...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Patterson-UTI Energy, Inc. ( NASDAQ:PTEN ) shares have had a really impressive month, gaining 25% after a shaky period...

With its stock down 25% over the past three months, it is easy to disregard Byrna Technologies (NASDAQ:BYRN). But if...

WisdomTree, Inc. ( NYSE:WT ) shareholders have had their patience rewarded with a 26% share price jump in the last...

We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many...

The board of AmeriServ Financial, Inc. ( NASDAQ:ASRV ) has announced that it will pay a dividend of $0.03 per share on...

Some Argan, Inc. ( NYSE:AGX ) shareholders may be a little concerned to see that the Independent Chairman, William...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Flotek Industries, Inc. ( NYSE:FTK ), might not be a large cap stock, but it led the NYSE gainers with a relatively...

Ingredion Incorporated's ( NYSE:INGR ) price-to-earnings (or "P/E") ratio of 11.2x might make it look like a buy right...

The AAR Corp. ( NYSE:AIR ) share price has done very well over the last month, posting an excellent gain of 26%. The...

Linde plc's ( NASDAQ:LIN ) price-to-earnings (or "P/E") ratio of 29.3x might make it look like a sell right now...

Cerus Corporation ( NASDAQ:CERS ) shares have continued their recent momentum with a 27% gain in the last month alone...

LSI Industries (NASDAQ:LYTS) has had a great run on the share market with its stock up by a significant 24% over the...

For us, stock picking is in large part the hunt for the truly magnificent stocks. Not every pick can be a winner, but...

Why Vir Biotechnology’s latest clinical data matters for investors Vir Biotechnology (VIR) recently reported new positive data from its SOLSTICE Phase 2 trial in chronic hepatitis delta, highlighting stronger and more sustained hepatitis delta virus RNA suppression for its tobevibart and elebsiran combination through 96 weeks. The company also used the 44th Annual J.P. Morgan Healthcare Conference to outline broader clinical plans, including the ECLIPSE Phase 3 program in hepatitis delta and...

Event-driven snapshot of Wolverine World Wide Wolverine World Wide (WWW) has drawn investor attention after recent share price swings, with the stock up around 10% over the past month but showing a decline across the past 3 months. See our latest analysis for Wolverine World Wide. At a share price of $19.28, Wolverine World Wide’s recent 10.05% 1 month share price return contrasts with its 26.24% 3 month share price decline and a 12.41% 1 year total shareholder return loss, suggesting...

If you are wondering whether Regeneron Pharmaceuticals at around US$755 per share still offers value, you are not alone. The answer depends on how you look at its fundamentals versus its current price. Over the last week the stock returned 1.8%, while the 30 day return was a 3.8% decline and the year to date return sits at a 2.7% decline, with a 9.4% return over the past year and 50.1% over five years. Investors have been watching Regeneron closely as fresh company specific news and sector...

Viatris (NasdaqGS:VTRS) has launched Inpefa, a dual SGLT1/2 inhibitor for heart failure, in the United Arab Emirates. This marks the company's first international commercial rollout of Inpefa. The launch introduces a first in class cardiovascular therapy to patients in the UAE. For you as an investor, this move highlights how Viatris is adding to its presence in branded treatments alongside its established portfolio. Cardiovascular care continues to be a major focus area for global...

LSI Industries (LYTS) has just posted Q2 2026 results with revenue of US$147.0 million and basic EPS of US$0.20, alongside trailing twelve month revenue of US$591.8 million and EPS of US$0.84 that frame the latest quarter against a fuller year of operations. The company has seen quarterly revenue move from US$147.7 million and EPS of US$0.19 in Q2 2025 to US$147.0 million and EPS of US$0.20 in Q2 2026, with net income shifting from US$5.6 million to US$6.3 million over the same period, while...

If you are wondering whether DXP Enterprises' current share price lines up with its underlying value, you are not alone. This article walks through what the numbers actually say. With the stock at US$132.09 and recent returns of 9.4% over 7 days, 14.4% over 30 days, 22.6% year to date and 23.4% over 1 year, many investors are reassessing both the growth potential and the level of risk they are comfortable with. DXP Enterprises has also been in the news for its role as a distributor and...